{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:36:01Z","timestamp":1783575361149,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41375-021-01314-1","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T17:03:05Z","timestamp":1623344585000},"page":"3589-3593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9522-7061","authenticated-orcid":false,"given":"Ron D.","family":"Jachimowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7208-4117","authenticated-orcid":false,"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther","family":"Glehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6895-4132","authenticated-orcid":false,"given":"Heinz","family":"Haverkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Thorns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Leo","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Rehberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"von Tresckow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Borchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Spang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-9750","authenticated-orcid":false,"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Altenbuchinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"1314_CR1","doi-asserted-by":"publisher","first-page":"iii70","DOI":"10.1093\/annonc\/mdu181","volume":"25","author":"DA Eichenauer","year":"2014","unstructured":"Eichenauer DA, Engert A, Andre M, Federico M, Illidge T, Hutchings M, et al. Hodgkin\u2019s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25:iii70\u20135.","journal-title":"Ann Oncol"},{"key":"1314_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1200\/JCO.2012.43.4589","volume":"31","author":"DW Scott","year":"2013","unstructured":"Scott DW, Chan FC, Hong F, Rogic S, Tan KL, Meissner B, et al. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. J Clin Oncol. 2013;31:692\u2013700.","journal-title":"J Clin Oncol"},{"key":"1314_CR3","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1200\/JCO.2010.33.9549","volume":"29","author":"P Borchmann","year":"2011","unstructured":"Borchmann P, Haverkamp H, Diehl V, Cerny T, Markova J, Ho AD, et al. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin\u2019s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group. J Clin Oncol. 2011;29:4234\u201342.","journal-title":"J Clin Oncol"},{"key":"1314_CR4","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(11)61940-5","volume":"379","author":"A Engert","year":"2012","unstructured":"Engert A, Haverkamp H, Kobe C, Markova J, Renner C, Ho A, et al. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin\u2019s lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet 2012;379:1791\u20139.","journal-title":"Lancet"},{"key":"1314_CR5","doi-asserted-by":"crossref","unstructured":"Jachimowicz RD, Pieper L, Reinke S, Gontarewicz A, Plutschow A, Haverkamp H, et al. Analysis of the tumor microenvironment by whole-slide image analysis identifies low B cell content as a predictor of adverse outcome in advanced-stage classical Hodgkin lymphoma treated with BEACOPP. Haematologica. 2020;106:1684\u201392.","DOI":"10.3324\/haematol.2019.243287"},{"key":"1314_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, et al. Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N Engl J Med. 2010;362:875\u201385.","journal-title":"N Engl J Med"},{"key":"1314_CR7","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3324\/haematol.2013.091561","volume":"98","author":"A Engert","year":"2013","unstructured":"Engert A. CD30-positive malignant lymphomas: time for a change of management? Haematologica. 2013;98:1165\u20138.","journal-title":"Haematologica."},{"key":"1314_CR8","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1182\/blood-2004-10-4008","volume":"105","author":"C Renne","year":"2005","unstructured":"Renne C, Willenbrock K, Kuppers R, Hansmann ML, Brauninger A. Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. Blood. 2005;105:4051\u20139.","journal-title":"Blood."},{"key":"1314_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ajh.23361","volume":"88","author":"M Sauer","year":"2013","unstructured":"Sauer M, Plutschow A, Jachimowicz RD, Kleefisch D, Reiners KS, Ponader S, et al. Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma. Am J Hematol. 2013;88:113\u20135.","journal-title":"Am J Hematol"},{"key":"1314_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1158\/1078-0432.CCR-12-2693","volume":"19","author":"K Jones","year":"2013","unstructured":"Jones K, Vari F, Keane C, Crooks P, Nourse JP, Seymour LA, et al. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Clin Cancer Res. 2013;19:731\u201342.","journal-title":"Clin Cancer Res"},{"key":"1314_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1182\/blood.V126.23.175.175","volume":"126","author":"A Mottok","year":"2015","unstructured":"Mottok A, Johnston RL, Chan FC, Scott DW, Friedman DL, Schwartz C, et al. Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients. Blood. 2015;126:175.","journal-title":"Blood."},{"key":"1314_CR12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1470-2045(13)70341-3","volume":"14","author":"N Skoetz","year":"2013","unstructured":"Skoetz N, Trelle S, Rancea M, Haverkamp H, Diehl V, Engert A, et al. Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin\u2019s lymphoma: a systematic review and network meta-analysis. Lancet Oncol. 2013;14:943\u201352.","journal-title":"Lancet Oncol"},{"key":"1314_CR13","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1182\/blood-2018-05-852129","volume":"132","author":"C Kobe","year":"2018","unstructured":"Kobe C, Goergen H, Baues C, Kuhnert G, Voltin CA, Zijlstra J, et al. Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma. Blood. 2018;132:2273\u20139.","journal-title":"Blood."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01314-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:42:20Z","timestamp":1684618940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01314-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1038\/s41375-021-01314-1","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Employment or Leadership Position: None; Consultant or Advisory Role: AE, Takeda, BMS; HCR, Abbvie, AstraZeneca; BvT, Amgen, Pfizer, Takeda, MSD; WK, Takeda; CS Seattle Genetics, Curis Inc., Roche, AbbVie, AstraZeneca, Juno Therapeutics, Bayer; Stock Ownership: None; Honoraria: AE, Takeda, BMS, WK, Takeda; BvT, Roche, Takeda, MSD; Research Funding: AE, Takeda, BMS, Affimed; HCR, Gilead Sciences; BvT, Novartis, MSD, Takeda; WK, Takeda, Amgen, Regeneron, Roche; CS. Bristol-Myers Squibb, Epizyme and Trillium Therapeutics Inc.; Expert Testimony: None; Other Remuneration: None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}